These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 14905410)

  • 21. Complications of testosterone therapy in the female; the use of methylandrostenediol as a substitute.
    ROBINSON WW
    West J Surg Obstet Gynecol; 1953 Feb; 61(2):79-82. PubMed ID: 13029453
    [No Abstract]   [Full Text] [Related]  

  • 22. [Hypertelorism and infantile cataract due to probable adrenocortical dysfunction; effect of methylandrostenediol].
    FERIN J; FRANCOIS J; DEVIS R
    Ann Endocrinol (Paris); 1952; 13(3):377-81. PubMed ID: 13017079
    [No Abstract]   [Full Text] [Related]  

  • 23. Hormonal therapy in cancer of the breast. XII. The effect of etiocholanolone therapy on clinical course and hormonal excretion.
    SEGALOFF A; BOWERS CY; GORDON DL; SCHLOSSER JV; MURISON PJ
    Cancer; 1957; 10(6):1116-8. PubMed ID: 13489660
    [No Abstract]   [Full Text] [Related]  

  • 24. Hormonal therapy in cancer of the breast. IV. Effect of androstenediol on clinical course and hormonal excretion.
    SEGALOFF A; HORWITT BN; GORDON D; MURISON PJ; SCHLOSSER JV
    Cancer; 1952 Nov; 5(6):1179-81. PubMed ID: 12998024
    [No Abstract]   [Full Text] [Related]  

  • 25. Hormonal therapy in cancer of the breast. XI. The effect of dehydroepiandrosterone on clinical course and hormonal excretion.
    SEGALOFF A; GORDON DL; BOWERS CY; SCHLOSSER JV; MURISON PJ
    Cancer; 1957; 10(6):1114-5. PubMed ID: 13489659
    [No Abstract]   [Full Text] [Related]  

  • 26. Oligospermia; a clinical study of treatment with methylandrostenediol.
    SCHULTZ JM
    Fertil Steril; 1956; 7(6):523-39. PubMed ID: 13375713
    [No Abstract]   [Full Text] [Related]  

  • 27. [Methylandrostenediol in old age; preliminary note].
    MONTEYS PORTA J
    Rev Iber Endocrinol; 1956; 3(13):81-4. PubMed ID: 13310960
    [No Abstract]   [Full Text] [Related]  

  • 28. Effective treatment of dysmenorrhea and menstrual molimina by the preovulatory administration of methyltestosterone or methylandrostenediol.
    KUPPERMAN HS; GOODMAN SJ
    Am J Obstet Gynecol; 1953 Jan; 65(1):141-9. PubMed ID: 13016681
    [No Abstract]   [Full Text] [Related]  

  • 29. Evaluation of an androgen, methylandrostenediol, in the treatment of diabetic retinopathy.
    GURLING KJ
    Br J Ophthalmol; 1955 Mar; 39(3):151-4. PubMed ID: 14363609
    [No Abstract]   [Full Text] [Related]  

  • 30. Hormonal therapy in cancer of the breast. V. The effect of methyltestosterone on clinical course and hormonal excretion.
    SEGALOFF A; HORWITT BN; CARABASI RA; MURISON PJ; SCHLOSSER JV
    Cancer; 1953 May; 6(3):483-7. PubMed ID: 13042772
    [No Abstract]   [Full Text] [Related]  

  • 31. Hormonal therapy in cancer of the breast. VIII. The effect of dihydrotestosterone (androstanolone) on clinical course and hormonal excretion.
    SEGALOFF A; HORWITT BN; CARABASI RA; MURISON PJ; SCHLOSSER JV
    Cancer; 1955; 8(1):82-6. PubMed ID: 13231036
    [No Abstract]   [Full Text] [Related]  

  • 32. [The danger of hormonal treatments at the beginning of pregnancy: a case of female pseudohermaphroditism due to methylandrostenediol].
    LAMY M; FREZAL J; JOSSO-MUHLSTEIN N; REY J; LAMBERT A; NETTER A
    Bull Fed Soc Gynecol Obstet Lang Fr; 1960; 12():147-56. PubMed ID: 14413728
    [No Abstract]   [Full Text] [Related]  

  • 33. [Effects of a new methylandrostenediol derivative (methylandrostenediol 3-propionate) on protein anabolism].
    MASSONS JM
    Rev Iber Endocrinol; 1955; 2(10):421-32. PubMed ID: 13290275
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of methylandrostenediol and its esters on protein anabolism. II..
    KOLLER M; ERCOLI A
    Boll Soc Ital Biol Sper; 1953 Feb; 29(2):137-9. PubMed ID: 13081761
    [No Abstract]   [Full Text] [Related]  

  • 35. [Methylandrostenediol: physiological effects; preliminary therapeutic results].
    NETTER A; CHEVALLIER J; MOLHO S
    Bull Mem Soc Med Hop Paris; 1952 Apr 25-May 2; 68(14-15):516-9. PubMed ID: 14954453
    [No Abstract]   [Full Text] [Related]  

  • 36. [Biological effect of methylandrostenediol; experimental and clinical studies].
    TRONCONI G
    Ann Ostet Ginecol; 1955 Jul; 77(7):657-86. PubMed ID: 13292814
    [No Abstract]   [Full Text] [Related]  

  • 37. Hormonal factors in the production of experimental renal and cardiovascular disease; synergism between somatotrophic hormone and methylandrostenediol.
    SALGADO E; SELYE H
    J Lab Clin Med; 1955 Feb; 45(2):237-46. PubMed ID: 13233650
    [No Abstract]   [Full Text] [Related]  

  • 38. [Androgenic effect of methylandrostenediol in animal experiment].
    ABT KR
    Gynaecologia; 1953 Apr; 135(4):214-7. PubMed ID: 13068672
    [No Abstract]   [Full Text] [Related]  

  • 39. Metabolic and clinical effects of methylandrostenediol in human subjects.
    PARTRIDGE JW; BOLING L; DEWIND L; MARGEN S; KINSELL LW
    J Clin Endocrinol Metab; 1953 Feb; 13(2):189-202. PubMed ID: 13034903
    [No Abstract]   [Full Text] [Related]  

  • 40. On a singular ovarian change produced by methylandrostenediol (MAD).
    SELYE H
    J Obstet Gynaecol Br Emp; 1955 Jun; 62(3):364-6. PubMed ID: 14392514
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.